lutetium (177lu) vipividotide tetraxetan
SpainDrugs containing this active substance
-
It is used in adults with metastatic castration-resistant prostate cancer that has spread to other parts of the body and who have already received other cancer treatments, provided that the cancer cells have a protein called PSMA on their surface.
Form: solution for injection and for infusion
Active substance Dosage lutetium (177lu) vipividotide tetraxetan 1000 MBq/ml Manufacturer: Novartis Europharm Limited